Skip to main content
. 2013 Nov 15;5:449–459. doi: 10.2147/CLEP.S53009

Table 2.

Association between maternal use of antidepressants during pregnancy, autism spectrum disorder, and childhood autism in the child, compared with children who were not exposed

AD exposure Number Person years at risk Autism spectrum disorder n (%) Crude HR (95% CI) Adjusted HRa (95% CI)
Autism spectrum disorder
Exposed to AD 8,833 65,234 104 (1.2) 1.8 (1.5–2.2) 1.5 (1.2–1.9)
Exposed to SSRI 7,506 55,015 91 (1.2) 1.9 (1.5–2.4) 1.6 (1.3–2.0)
Exposed to SNRI 673 4,463 7 (1.0) 1.9 (0.9–4.0) 1.7 (0.8–3.5)
Exposed to TCA 642 5,387 9 (1.4) 1.8 (0.95–3.5) 1.5 (0.8–2.9)
Not exposed to AD 646,782 5,733,033 5,333 (0.8) 1.0 (ref) 1.0 (ref)

AD exposure Number Person years at risk Childhood autism n (%) Crude HR (95% CI) Adjusted HRa(95% CI)

Childhood autism
Exposed to AD 8,833 65,390 37 (0.4) 1.5 (1.1–2.1) 1.3 (0.9–1.8)
Exposed to SSRI 7,506 55,142 34 (0.5) 1.6 (1.1–2.3) 1.4 (0.9–2.0)
Exposed to SNRI 673 4,481 1 (0.1) NA NA
Exposed to TCA 642 5,407 2 (0.3) NA NA
Not exposed to AD 646,782 5,743,343 2,030 (0.3) 1.0 (ref) 1.0 (ref)

Notes:

a

Hazard ratios were adjusted for maternal age at conception, paternal age at conception, parental psychiatric history (except maternal affective disorder), gestational age, birth weight, sex, and parity.

Abbreviations: AD, antidepressant drugs; HR, hazard ratio; n, number; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin–norepinephrine reuptake inhibitors; TCA, tricyclic antidepressants; ref, reference; NA, not applicable; CI, confidence interval.